Additional Listing (4912U)
December 22 2011 - 5:39AM
UK Regulatory
TIDMHIK
RNS Number : 4912U
Hikma Pharmaceuticals Plc
22 December 2011
Block Listing of Shares
Hikma Pharmaceuticals PLC
LONDON, 22 December 2011 - The Board of Hikma Pharmaceuticals
PLC ("Hikma") (LSE: HIK) (NASDAQ: HIK), announces that it has made
a block listing application to the Financial Services Authority and
the London Stock Exchange plc for a total of 1,070,000 ordinary
shares of 10p each in the capital of the Company to be admitted to
the Official List of the UK Listing Authority. It is expected that
admission will be granted on 22 December 2011 and trading will
commence on 23 December 2011.
The shares, when issued, will be issued fully paid and rank pari
passu in all respects with the existing issued ordinary shares of
the Company. The shares will be issued pursuant to the vesting of
shares under the Hikma Pharmaceuticals PLC 2005 Long Term Incentive
Plan (the "Plan"). Participants in the Plan have or will become
entitled to these shares following the vesting of the shares.
- ENDS -
Enquiries:
Hikma Pharmaceuticals PLC
Henry Knowles
Company Secretary +44 20 7399 2670
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed pharmaceutical
products. Hikma's operations are conducted through three
businesses: "Branded", "Injectables" and "Generics". Hikma's
operations are based principally in the Middle East and North
Africa ("MENA") region, where it is a market leader and sells
across 17 countries, the United States and Europe. In 2010, the
Group achieved revenues of $731 million (2009 $637 million) and
profit attributable to shareholders was $99 million (2009 $78
million).
This information is provided by RNS
The company news service from the London Stock Exchange
END
LISPGGMWPUPGGUP
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024